Literature DB >> 20213586

Antidiabetic effect of Gynostemma pentaphyllum tea in randomly assigned type 2 diabetic patients.

V T T Huyen1, D V Phan, P Thang, N K Hoa, C G Ostenson.   

Abstract

The aim of the study was to investigate the antidiabetic effect of the traditional Vietnamese herb Gynostemma pentaphyllum in 24 drug-naïve type 2 diabetic patients. All patients were randomized to authenticated Gynostemma pentaphyllum tea or placebo tea, 6 g daily, during twelve weeks and received information regarding diet and exercise. Fasting plasma glucose, insulin levels, and glycosylated hemoglobin (HbA(1C)) were measured before, during, and after the treatment. Oral glucose tolerance tests were performed every four weeks. After 12-week treatment, fasting plasma glucose levels totally decreased to an extent of 3.0+/-1.8 mmol/l in the Gynostemma pentaphyllum tea group as compared to a decrease of 0.6+/-2.2 mmol/l in the control group (p<0.01). HbA(1C) levels after 12 weeks decreased approximately 2% units in the Gynostemma pentaphyllum group compared to 0.2% unit in the controls (p<0.001). Change in Homeostasis Model Assessment-Insulin Resistance between baseline and twelfth week indicated that insulin resistance decreased significantly in the Gynostemma pentaphyllum group (-2.1+/-3.0) compared with that (+1.1+/-3.3) in the control group (p<0.05). There were no hypoglycemias, or adverse effects regarding kidney and liver parameters or gastrointestinal function. In addition, lipid profiles, glucagon, cortisol levels, body measurements, and blood pressure were not different between the groups. This study shows a prompt improvement of glycemia and insulin sensitivity, and thereby provides a basis for a novel, effective, and safe approach, using Gynostemma pentaphyllum tea, to treat type 2 diabetic patients. Georg Thieme Verlag KG Stuttgart-New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20213586     DOI: 10.1055/s-0030-1248298

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  15 in total

1.  Transcriptome profiling and insilico analysis of Gynostemma pentaphyllum using a next generation sequencer.

Authors:  Sathiyamoorthy Subramaniyam; Ramya Mathiyalagan; In Jun Gyo; Lee Bum-Soo; Lee Sungyoung; Yang Deok Chun
Journal:  Plant Cell Rep       Date:  2011-07-19       Impact factor: 4.570

2.  Herbal constituent sequoyitol improves hyperglycemia and glucose intolerance by targeting hepatocytes, adipocytes, and β-cells.

Authors:  Hong Shen; Mengle Shao; Kae Won Cho; Suqing Wang; Zheng Chen; Liang Sheng; Ting Wang; Yong Liu; Liangyou Rui
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-31       Impact factor: 4.310

Review 3.  Non-Alcoholic Fatty Liver Disease, an Overview.

Authors:  Asia Muhammad Nd
Journal:  Integr Med (Encinitas)       Date:  2019-04

4.  Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis.

Authors:  Kaushik Chattopadhyay; Haiquan Wang; Jaspreet Kaur; Gamze Nalbant; Abdullah Almaqhawi; Burak Kundakci; Jeemon Panniyammakal; Michael Heinrich; Sarah Anne Lewis; Sheila Margaret Greenfield; Nikhil Tandon; Tuhin Kanti Biswas; Sanjay Kinra; Jo Leonardi-Bee
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

5.  Gynostemma pentaphyllum Tea Improves Insulin Sensitivity in Type 2 Diabetic Patients.

Authors:  V T T Huyen; D V Phan; P Thang; N K Hoa; C G Ostenson
Journal:  J Nutr Metab       Date:  2013-01-31

6.  Tea consumption and incidence of type 2 diabetes in Europe: the EPIC-InterAct case-cohort study.

Authors:  Geertruida J van Woudenbergh; Anneleen Kuijsten; Dagmar Drogan; Daphne L van der A; Dora Romaguera; Eva Ardanaz; Pilar Amiano; Aurelio Barricarte; Joline W J Beulens; Heiner Boeing; H Bas Bueno-de-Mesquita; Christina C Dahm; M-Doleres Chirlaque; Francoise Clavel; Francesca L Crowe; Piia-Piret Eomois; Guy Fagherazzi; Paul W Franks; Jytte Halkjaer; Kay T Khaw; Giovanna Masala; Amalia Mattiello; Peter Nilsson; Kim Overvad; J Ramón Quirós; Olov Rolandsson; Isabelle Romieu; Carlotta Sacerdote; María-José Sánchez; Matthias B Schulze; Nadia Slimani; Ivonne Sluijs; Annemieke M W Spijkerman; Giovanna Tagliabue; Anne Tjønneland; Rosario Tumino; Nita G Forouhi; Stephen Sharp; Claudia Langenberg; Edith J M Feskens; Elio Riboli; Nicholas J Wareham
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

7.  Evaluation of Antidiabetic Effects of the Traditional Medicinal Plant Gynostemma pentaphyllum and the Possible Mechanisms of Insulin Release.

Authors:  Ezarul Faradianna Lokman; Harvest F Gu; Wan Nazaimoon Wan Mohamud; Claes-Göran Östenson
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-23       Impact factor: 2.629

8.  Gypenoside L inhibits autophagic flux and induces cell death in human esophageal cancer cells through endoplasm reticulum stress-mediated Ca2+ release.

Authors:  Chenghui Liao; Kai Zheng; Yan Li; Hong Xu; Qiangrong Kang; Long Fan; Xiaopeng Hu; Zhe Jin; Yong Zeng; Xiaoli Kong; Jian Zhang; Xuli Wu; Haiqiang Wu; Lizhong Liu; Xiaohua Xiao; Yifei Wang; Zhendan He
Journal:  Oncotarget       Date:  2016-07-26

9.  Antidiabetic Effects of Add-On Gynostemma pentaphyllum Extract Therapy with Sulfonylureas in Type 2 Diabetic Patients.

Authors:  V T T Huyen; D V Phan; P Thang; P T Ky; N K Hoa; C G Ostenson
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-17       Impact factor: 2.629

10.  Herbal extract of gynostemma pentaphyllum decreases hepatic glucose output in type 2 diabetic goto-kakizaki rats.

Authors:  K Yassin; V T T Huyen; K N Hoa; C G Ostenson
Journal:  Int J Biomed Sci       Date:  2011-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.